Medical Condition News

RSS

SKY92 genetic subtyping signature better than current markers in predicting progress of multiple myeloma

Article in Blood shows the reliability of SKY92 genetic subtyping signature for prediction of disease progress for multiple myeloma patient.

9 Sep 2015

Study: Wildfire smoke exposure associated with increased visits to ER for asthma

Researchers who analyzed data from the 2006-2007 wildfires in Australia found that exposure to wildfire smoke was linked to increased visits to hospital emergency departments for asthma.

9 Sep 2015

Researchers find answer to continuing debate in the cardiovascular scientific world

Researchers from the University of Ottawa Heart Institute, together with the teams of Dr. Martin Farrell at Oxford University, and Dr. Sekar Kathiresan at the Broad Institute, have found the answer to an ongoing debate in the cardiovascular scientific world. Dr. Ruth McPherson and Dr. Majid Nikpay, researchers at the UOHI's Ruddy Canadian Cardiovascular Genetics Centre, report that the genetic basis of heart disease is largely derived from the cumulative effect of multiple common genetic variants, rather than from a few rare variants with large effects.

9 Sep 2015

Diabetes often goes undiagnosed in more than half of Asian Americans

More than half of Asian Americans and nearly half of Hispanic Americans with diabetes are undiagnosed, according to researchers from the National Institutes of Health and the Centers for Disease Control and Prevention.

9 Sep 2015

Researchers identify new way to help AML patients avoid a relapse

A protein domain once considered of little importance may be key to helping patients who are fighting acute myeloid leukemia (AML) avoid a relapse.

8 Sep 2015

Novel research tool identifies link between negative symptoms of schizophrenia and adverse clinical outcomes

A novel research tool developed by researchers from the Institute of Psychiatry, Psychology & Neuroscience at King's College London has identified a link between the negative symptoms experienced by people with schizophrenia and adverse clinical outcomes.

8 Sep 2015

Oxis Biotech executes worldwide license agreement to develop, commercialize novel cancer therapy

Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.

8 Sep 2015

FDA grants Orphan Drug designation to Rigel's Fostamatinib for treatment of patients with ITP

Rigel Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has granted Orphan Drug designation to Fostamatinib, Rigel's oral spleen tyrosine kinase (SYK) inhibitor which is currently in Phase 3 clinical studies in patients with chronic immune thrombocytopenic purpura (ITP).

8 Sep 2015

IRIDEX launches novel intra-ocular pressure monitoring device

IRIDEX Corporation today announced that it has added a novel intra-ocular pressure (IOP) monitoring device called a tonometer to its suite of commercial products for the global glaucoma market. The new device comes to IRIDEX through a distribution agreement with Icare Finland Plc, a subsidiary of the Revenio Group Corporation, the creator of the tonometer.

8 Sep 2015

Helsinn, BIAL sign exclusive distribution and licence agreement for Anamorelin

Helsinn, the Swiss Group focused on building quality cancer care, and BIAL - Portela & Ca. S.A., one of the largest Iberian pharmaceutical companies, today announce that they have entered into an agreement for the exclusive distribution and licence rights to Anamorelin in Spain, Portugal, Angola and Mozambique.

8 Sep 2015

DCR launches Biospecimen Research Grant Program

DaVita Clinical Research, a specialty contract research organization with services spanning a broad spectrum of drug and device development, announced today its Biospecimen Research Grant Program (BioReG), a grant program to award clinical-trial-quality biospecimens and annotated de-identified data to academic medical centers involved in kidney research.

8 Sep 2015

Scientists discover mechanism that could lead to new treatment for allergies

Most people with allergies have to take medication throughout their life: Their body "thinks" that proteins from the environment are so "strange" that they elicit an immune reaction. Until present, it was not possible to develop an efficient therapy so that the body "learns" to stop in an overreacting way.

8 Sep 2015

Lund University researchers reveal how the body develops acute pancreatitis

Researchers at Lund University in Sweden may have discovered one of the keys to understanding how the body develops acute pancreatitis. The results offer hope for the development of drugs that specifically target the disease.

8 Sep 2015

AstraZeneca presents lung cancer research data at WCLC 2015

Data will be reported from across AstraZeneca’s industry-leading lung cancer portfolio at the World Conference on Lung Cancer 2015, beginning this weekend in Denver, Colorado.

8 Sep 2015

Studies suggests that insular cortex may hold key to treating addiction

A pair of studies suggests that a region of the brain - called the insular cortex - may hold the key to treating addiction. Scientists have come to this conclusion after finding that smokers who suffered a stroke in the insular cortex were far more likely to quit smoking and experience fewer and less severe withdrawal symptoms than those with strokes in other parts of the brain.

8 Sep 2015

New study reveals pivotal role of miR-506 biomarker in gastric cancer

Gastric cancer poses a significant health problem in developing countries and is typically associated with late-stage diagnosis and high mortality. A new study in The American Journal of Pathology points to a pivotal role played by the biomarker microRNA (miR)-506 in gastric cancer.

8 Sep 2015

AMRA, Pfizer collaborate to assess fat and muscle measurements to predict obesity, diabetes

AMRA announced that they have entered into a unique international collaboration with Pfizer Inc. to investigate the relationship between fat and muscle distribution in the body and metabolic health, including risk factors for conditions such as obesity and diabetes.

8 Sep 2015

Desmoplasmic melanoma may possess unprecedented burden of gene mutations, say UCSF scientists

A rare, deadly form of skin cancer known as desmoplasmic melanoma (DM) may possess the highest burden of gene mutations of any cancer, suggesting that immunotherapy may be a promising approach for treatment, according to an international team led by UC San Francisco scientists. One of these mutations, never before observed in any cancer, may shield nascent DM tumors from destruction by the immune system and allow further mutations to develop.

7 Sep 2015

Study: Men and women with autism perform differently on 'Reading the Mind in the Eyes' test

Scientists at the University of Cambridge University have published new results in the journal PLoS ONE from the largest ever study of people with autism taking the 'Reading the Mind in the Eyes' test.

7 Sep 2015

Optimising Insulin Pump Therapy symposium to be held in Stockholm on 14 September, 2015

A symposium on optimising insulin pump therapy, particularly focused on infusion set failures, will be held in advance of the 51st European Association for the Study of Diabetes Annual Meeting on 14th September 2015 in Stockholm.

7 Sep 2015

Medical Condition News

SKY92 genetic subtyping signature better than current markers in predicting progress of multiple myeloma

Study: Wildfire smoke exposure associated with increased visits to ER for asthma

Researchers find answer to continuing debate in the cardiovascular scientific world

Diabetes often goes undiagnosed in more than half of Asian Americans

Researchers identify new way to help AML patients avoid a relapse

Novel research tool identifies link between negative symptoms of schizophrenia and adverse clinical outcomes

Oxis Biotech executes worldwide license agreement to develop, commercialize novel cancer therapy

FDA grants Orphan Drug designation to Rigel's Fostamatinib for treatment of patients with ITP

IRIDEX launches novel intra-ocular pressure monitoring device

Helsinn, BIAL sign exclusive distribution and licence agreement for Anamorelin

DCR launches Biospecimen Research Grant Program

Scientists discover mechanism that could lead to new treatment for allergies

Lund University researchers reveal how the body develops acute pancreatitis

AstraZeneca presents lung cancer research data at WCLC 2015

Studies suggests that insular cortex may hold key to treating addiction

New study reveals pivotal role of miR-506 biomarker in gastric cancer

AMRA, Pfizer collaborate to assess fat and muscle measurements to predict obesity, diabetes

Desmoplasmic melanoma may possess unprecedented burden of gene mutations, say UCSF scientists

Study: Men and women with autism perform differently on 'Reading the Mind in the Eyes' test

Optimising Insulin Pump Therapy symposium to be held in Stockholm on 14 September, 2015

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News